Meghan T Murray1, Rozelle Corda2, Rebecca Turcotte3, Emile Bacha4, Lisa Saiman5, Ganga Krishnamurthy6. 1. School of Nursing, Columbia University Medical Center, New York, New York. 2. School of Nursing, Columbia University Medical Center, New York, New York; Department of Surgery, Columbia University Medical Center, New York, New York. 3. Department of Pediatrics, Columbia University Medical Center, New York, New York. 4. Department of Surgery, Columbia University Medical Center, New York, New York. 5. Department of Pediatrics, Columbia University Medical Center, New York, New York; Department of Infection Prevention and Control, New York-Presbyterian Hospital, New York, New York. 6. Department of Pediatrics, Columbia University Medical Center, New York, New York. Electronic address: gk2008@columbia.edu.
Abstract
BACKGROUND: A lack of perioperative antibiotic prophylaxis guidelines for neonates undergoing cardiac surgery has resulted in a wide variation in practice. We sought to do the following: (1) Determine the safety of a perioperative antibiotic prophylaxis protocol for neonatal cardiac surgery as measured by surgical site infections (SSIs) rates before and after implementation of the protocol; and (2) evaluate compliance with selected process measures for perioperative antibiotic prophylaxis. METHODS: This quasi-experimental study included all cardiac procedures performed on neonates from July 2009 to June 2012 at a single center. An interdisciplinary task force developed a standardized perioperative antibiotic prophylaxis protocol in the fourth quarter of 2010. The SSI rates were compared in the preintervention (July 2009 to December 2010) versus the postintervention periods (January 2011 to June 2012). Compliance with process measures (appropriate drug, dose, timing, and discontinuation of perioperative antibiotic prophylaxis) was compared in the 2 periods. RESULTS: During the study period, 283 cardiac procedures were performed. The SSI rates were similar in the preintervention and postintervention periods (6.21 vs 5.80 per 100 procedures, respectively). Compliance with the 4 process measures significantly improved postintervention. CONCLUSIONS: Restricting the duration of perioperative antibiotic prophylaxis after neonatal cardiac surgery to 48 hours in neonates with a closed sternum and to 24 hours after sternal closure was safe and did not increase the rate of SSIs. Compliance with selected process measures improved in the postintervention period. Additional multicenter studies are needed to develop national guidelines for perioperative prophylaxis for this population.
BACKGROUND: A lack of perioperative antibiotic prophylaxis guidelines for neonates undergoing cardiac surgery has resulted in a wide variation in practice. We sought to do the following: (1) Determine the safety of a perioperative antibiotic prophylaxis protocol for neonatal cardiac surgery as measured by surgical site infections (SSIs) rates before and after implementation of the protocol; and (2) evaluate compliance with selected process measures for perioperative antibiotic prophylaxis. METHODS: This quasi-experimental study included all cardiac procedures performed on neonates from July 2009 to June 2012 at a single center. An interdisciplinary task force developed a standardized perioperative antibiotic prophylaxis protocol in the fourth quarter of 2010. The SSI rates were compared in the preintervention (July 2009 to December 2010) versus the postintervention periods (January 2011 to June 2012). Compliance with process measures (appropriate drug, dose, timing, and discontinuation of perioperative antibiotic prophylaxis) was compared in the 2 periods. RESULTS: During the study period, 283 cardiac procedures were performed. The SSI rates were similar in the preintervention and postintervention periods (6.21 vs 5.80 per 100 procedures, respectively). Compliance with the 4 process measures significantly improved postintervention. CONCLUSIONS: Restricting the duration of perioperative antibiotic prophylaxis after neonatal cardiac surgery to 48 hours in neonates with a closed sternum and to 24 hours after sternal closure was safe and did not increase the rate of SSIs. Compliance with selected process measures improved in the postintervention period. Additional multicenter studies are needed to develop national guidelines for perioperative prophylaxis for this population.
Authors: Kevin O Maher; Kristen VanDerElzen; Edward L Bove; Ralph S Mosca; Carol E Chenoweth; Thomas J Kulik Journal: Ann Thorac Surg Date: 2002-10 Impact factor: 4.330
Authors: I Levy; B Ovadia; E Erez; S Rinat; S Ashkenazi; E Birk; H Konisberger; B Vidne; O Dagan Journal: J Hosp Infect Date: 2003-02 Impact factor: 3.926
Authors: Tia A Tortoriello; Jeffrey D Friedman; E Dean McKenzie; Charles D Fraser; Timothy F Feltes; Jessica Randall; Antonio R Mott Journal: Ann Thorac Surg Date: 2003-11 Impact factor: 4.330
Authors: Ralph Gertler; Michael Gruber; Gunther Wiesner; Stanislas Grassin-Delyle; Saïk Urien; Peter Tassani-Prell; Klaus Martin Journal: Br J Clin Pharmacol Date: 2018-06-15 Impact factor: 4.335
Authors: Joseph Philip; Christian Kegg; Dalia Lopez-Colon; Brian J Kelly; Robert M Lawrence; Matthew A Robinson; Ravi S Samraj; Mark S Bleiweis Journal: J Intensive Care Med Date: 2018-08-08 Impact factor: 2.889